Cord Blood Transplantation for Hematologic Malignancies: Improving Access and Outcomes

VIDEO | 04:00

Cryopreserved umbilical cord blood is a promising alternative source for hematopoietic stem cells used in stem cell transplantation. Juliet Barker, MBBS, director of the Cord Blood Transplantation Program at Memorial Sloan Kettering Cancer Center, reviews recent research showing that cord blood can extend transplant access for most patients, including minority patients without other donor options. Most encouraging are results showing comparable survival rates to related and unrelated donor transplants. Dr. Barker also discusses double-unit cord blood strategies.